Trial Profile
A safety and efficacy study of everolimus in heart transplant recipients : A single center experience
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 23 Nov 2016
Price :
$35
*
At a glance
- Drugs Everolimus (Primary) ; Mycophenolate mofetil
- Indications Heart transplant rejection
- Focus Adverse reactions; Therapeutic Use
- 23 Nov 2016 New trial record